Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

ClinicalTrials.gov ID: NCT03337906

Public ClinicalTrials.gov record NCT03337906. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 7, 2026, 6:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

An observational study of long-term outcomes of HIV-1 infection in persons who become infected after enrollment in HIV-1 vaccine trials

Study identification

NCT ID
NCT03337906
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
HIV Vaccine Trials Network
Network
Enrollment
209 participants

Conditions and interventions

Conditions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 11, 2008 (Actual)
Primary completion
Jul 11, 2015 (Actual)
Completion
Jul 1, 2016 (Actual)
Last update posted
Apr 18, 2022

2008 – 2016

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
Alabama Vaccine CRS Birmingham Alabama 35294 —
Bridge HIV CRS San Francisco California 94143 —
The Hope Clinic of the Emory Vaccine Center CRS Decatur Georgia 30030 —
UIC Project WISH CRS Chicago Illinois 60612 —
Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston Massachusetts 02115-6110 —
Fenway Health Clinical Research Site CRS Boston Massachusetts 02215-4302 —
NY Blood Ctr./Union Square CRS New York New York 10003 —
Columbia P&S CRS New York New York 10032-3732 —
NY Blood Ctr./Bronx CRS New York New York 10455 —
University of Rochester Vaccines to Prevent HIV Infection CRS New York New York 14642 —
Penn Prevention CRS Philadelphia Pennsylvania 19104 —
Vanderbilt Vaccine (VV) CRS Nashville Tennessee 37232-2582 —
Seattle Vaccine and Prevention CRS Seattle Washington 98109-1024 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03337906, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2022 · Synced Oct 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03337906 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →